Skip to main content
IONIS PHARMACEUTICALS INC logo

IONIS PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · IONS ISIN · US4622221004 LEI · 549300SI4ZGLG0BLUZ92 US Manufacturing
Filings indexed 1,796 across all filing types
Latest filing 2025-08-05 Director's Dealing
Country US United States of America
Listing US IONS

About IONIS PHARMACEUTICALS INC

https://www.ionis.com/

Ionis Pharmaceuticals, Inc. is a biopharmaceutical company that discovers and develops RNA- and DNA-targeted therapeutics. Leveraging its expertise in antisense technology and a deep understanding of genetics, the company creates novel medicines designed to treat a wide range of serious diseases. Its development pipeline and marketed products primarily address neurologic and cardiometabolic disorders, as well as other areas with high unmet patient needs, including rare diseases. The company's approach aims to provide new solutions for complex and often intractable conditions by targeting the root cause of disease at the genetic level.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2025-08-05 English
Regulatory Filings 2025
Regulatory Filings
2025-08-05 English
Regulatory Filings 2025
Regulatory Filings
2025-08-04 English
PRIMARY DOCUMENT
Director's Dealing
2025-08-01 English
Regulatory Filings 2025
Regulatory Filings
2025-07-30 English
S-8
Share Issue/Capital Change Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as equity incentive plans. It includes detailed information about the plan, indemnification of directors and officers, exhibits related to corporate governance documents, and references to other SEC filings like 10-Ks and 10-Qs. It is not an annual report, earnings release, or any other financial report but a registration statement related to share issuance under an equity incentive plan. According to the filing definitions, this type of document is best classified under 'Share Issue/Capital Change' (SHA) because it relates to new share issuance under an equity plan.
2025-07-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.